Advocacy intelligence hub — real-time data for patient organizations
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
Kimmtrak
Immunocore Ltd
Kimmtrak
(tebentafusp-tebn)Orphan drugImmunocore Ltd
Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC]
12.1 Mechanism of Action Tebentafusp-tebn is a bispecific gp100 peptide-HLA-A*02:01 directed T cell receptor CD3 T cell engager. The TCR arm binds to ...
Gustav Stålhammar, MD PhD
St. Erik Eye Hospital and Karolinska Institutet
Takami Sato, MD, M.D
Thomas Jefferson University
📍 PHILADELPHIA, PA
Lars Ny
Department of Oncology, Sahlgrenska University Hospital, Sweden
Jeffrey Weber
University of Southern California
Shaheer A Khan, DO
Assistant Professor of Medicine at the Columbia University Medical Center
📍 DALLAS, TX
Alexander Shoushtari, MD, M.D
Memorial Sloan Kettering Cancer Center
📍 NEW YORK, NY